SIMILAR PATTERNS OF AMINO ACIDS FOR 4XV2_B_P06B801

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1cm8 PHOSPHORYLATED MAP
KINASE P38-GAMMA

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  54
LYS A  56
LEU A  78
ASP A 171
PHE A 172
 ANP  A 400 (-3.3A)
ANP  A 400 (-2.9A)
None
MG  A 402 (-2.3A)
None
 0.85A 4xv2B-1cm8A:
21.6		 4xv2B-1cm8A:
25.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1h4l CELL DIVISION
PROTEIN KINASE 5

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  31
LYS A  33
LEU A  55
CYH A  83
PHE A 145
 None
 0.90A 4xv2B-1h4lA:
18.1		 4xv2B-1h4lA:
23.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1k9a CARBOXYL-TERMINAL
SRC KINASE

(Rattus
norvegicus) 		PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr) 		5 ALA A 220
LYS A 222
THR A 266
ASP A 332
PHE A 333
 None
 0.88A 4xv2B-1k9aA:
27.8		 4xv2B-1k9aA:
22.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1q8y SR PROTEIN KINASE

(Saccharomyces
cerevisiae) 		PF00069
(Pkinase) 		5 ALA A 185
LYS A 187
LEU A 206
LEU A 226
ASP A 550
 ADP  A 810 (-3.3A)
ADP  A 810 (-3.1A)
None
ADP  A 810 (-4.4A)
ADP  A 810 ( 3.0A)
 0.86A 4xv2B-1q8yA:
21.2		 4xv2B-1q8yA:
24.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u5q SERINE/THREONINE
PROTEIN KINASE TAO2

(Rattus
norvegicus) 		PF00069
(Pkinase) 		7 ALA A  55
LYS A  57
LEU A  80
CYH A 108
GLY A 168
ASP A 169
PHE A 170
 None
 0.92A 4xv2B-1u5qA:
24.5		 4xv2B-1u5qA:
29.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zlt SERINE/THREONINE-PRO
TEIN KINASE CHK1

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  36
LYS A  38
CYH A  87
ASP A 148
PHE A 149
 HYM  A 400 (-3.5A)
HYM  A 400 (-3.2A)
HYM  A 400 (-4.2A)
HYM  A 400 (-3.9A)
None
 0.67A 4xv2B-1zltA:
14.5		 4xv2B-1zltA:
26.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zws DAP-KINASE RELATED
PROTEIN 1

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  40
LYS A  42
LEU A  68
ASP A 161
PHE A 162
 None
 0.84A 4xv2B-1zwsA:
24.2		 4xv2B-1zwsA:
26.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zy4 SERINE/THREONINE-PRO
TEIN KINASE GCN2

(Saccharomyces
cerevisiae) 		PF00069
(Pkinase) 		6 ALA A 626
LEU A 647
CYH A 791
PHE A 842
GLY A 852
PHE A 854
 GOL  A 998 ( 3.7A)
None
GOL  A 998 (-4.3A)
GOL  A 998 ( 4.2A)
None
None
 0.93A 4xv2B-1zy4A:
22.3		 4xv2B-1zy4A:
28.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2a1a INTERFERON-INDUCED,
DOUBLE-STRANDED
RNA-ACTIVATED
PROTEIN KINASE

(Homo sapiens) 		PF00069
(Pkinase) 		6 LYS B 296
CYH B 369
PHE B 421
GLY B 431
ASP B 432
PHE B 433
 None
 0.86A 4xv2B-2a1aB:
22.1		 4xv2B-2a1aB:
30.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2a2a DEATH-ASSOCIATED
PROTEIN KINASE 2

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  40
LYS A  42
LEU A  68
ASP A 161
PHE A 162
 GOL  A3001 (-3.5A)
None
None
None
None
 0.71A 4xv2B-2a2aA:
24.2		 4xv2B-2a2aA:
25.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2dq7 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE FYN

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA X  37
LYS X  39
THR X  82
ASP X 148
PHE X 149
 STU  X 902 (-3.1A)
STU  X 902 (-3.1A)
STU  X 902 (-4.1A)
STU  X 902 (-3.6A)
None
 0.71A 4xv2B-2dq7X:
21.8		 4xv2B-2dq7X:
32.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2eu9 DUAL SPECIFICITY
PROTEIN KINASE CLK3

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A 184
LYS A 186
LEU A 205
ASP A 320
PHE A 321
 None
 0.75A 4xv2B-2eu9A:
22.1		 4xv2B-2eu9A:
24.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2gcd SERINE/THREONINE-PRO
TEIN KINASE TAO2

(Rattus
norvegicus) 		PF00069
(Pkinase) 		6 ALA A  55
LEU A  80
CYH A 108
GLY A 168
ASP A 169
PHE A 170
 STU  A 400 (-3.2A)
None
STU  A 400 (-4.0A)
None
STU  A 400 (-3.6A)
None
 0.79A 4xv2B-2gcdA:
25.8		 4xv2B-2gcdA:
30.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2i6l MITOGEN-ACTIVATED
PROTEIN KINASE 6

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  47
LYS A  49
PHE A 159
GLY A 170
PHE A 172
 None
 0.66A 4xv2B-2i6lA:
23.6		 4xv2B-2i6lA:
27.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2j0j FOCAL ADHESION
KINASE 1

(Gallus gallus) 		PF00373
(FERM_M)
PF07714
(Pkinase_Tyr) 		6 ALA A 452
LYS A 454
CYH A 502
GLY A 563
ASP A 564
PHE A 565
 4ST  A1687 (-3.3A)
4ST  A1687 (-3.4A)
4ST  A1687 (-4.1A)
None
4ST  A1687 (-4.7A)
None
 1.01A 4xv2B-2j0jA:
28.8		 4xv2B-2j0jA:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jgz CELL DIVISION
PROTEIN KINASE 2

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  31
LYS A  33
LEU A  55
ASP A 145
PHE A 146
 None
 0.97A 4xv2B-2jgzA:
24.2		 4xv2B-2jgzA:
25.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jkm FOCAL ADHESION
KINASE 1

(Gallus gallus) 		PF07714
(Pkinase_Tyr) 		5 ALA A 452
LYS A 454
CYH A 502
GLY A 563
PHE A 565
 BII  A1687 (-3.5A)
BII  A1687 (-2.9A)
BII  A1687 (-4.1A)
BII  A1687 ( 3.9A)
None
 0.82A 4xv2B-2jkmA:
28.6		 4xv2B-2jkmA:
28.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ogv MACROPHAGE
COLONY-STIMULATING
FACTOR 1 RECEPTOR
PRECURSOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 ALA A 614
LYS A 616
THR A 663
CYH A 666
GLY A 795
ASP A 796
 None
 0.90A 4xv2B-2ogvA:
25.6		 4xv2B-2ogvA:
28.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2phk PHOSPHORYLASE KINASE

(Oryctolagus
cuniculus) 		PF00069
(Pkinase) 		5 ALA A  46
LYS A  48
LEU A  77
ASP A 167
PHE A 168
 ATP  A 381 (-3.5A)
ATP  A 381 (-3.2A)
None
MN  A 382 (-2.0A)
None
 0.92A 4xv2B-2phkA:
23.8		 4xv2B-2phkA:
28.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pmi CYCLIN-DEPENDENT
PROTEIN KINASE PHO85

(Saccharomyces
cerevisiae) 		PF00069
(Pkinase) 		5 ALA A  34
LYS A  36
GLY A 150
ASP A 151
PHE A 152
 AGS  A3001 (-3.5A)
AGS  A3001 (-3.4A)
None
AGS  A3001 (-2.8A)
None
 0.91A 4xv2B-2pmiA:
22.0		 4xv2B-2pmiA:
27.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pmo SER/THR PROTEIN
KINASE

(Plasmodium
falciparum) 		PF00069
(Pkinase) 		5 ALA X  53
LYS X  55
LEU X 101
ASP X 190
PHE X 191
 HMD  X 400 (-3.5A)
HMD  X 400 (-4.2A)
HMD  X 400 (-4.2A)
HMD  X 400 (-3.7A)
None
 0.65A 4xv2B-2pmoX:
22.4		 4xv2B-2pmoX:
24.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qlu ACTIVIN RECEPTOR
TYPE IIB

(Homo sapiens) 		PF00069
(Pkinase) 		6 ALA A 215
LYS A 217
LEU A 245
THR A 265
ASP A 339
PHE A 340
 ADE  A 488 (-3.2A)
None
ADE  A 488 ( 4.5A)
ADE  A 488 (-4.3A)
None
None
 0.87A 4xv2B-2qluA:
25.6		 4xv2B-2qluA:
27.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus musculus) 		PF00069
(Pkinase) 		6 ALA A 449
LYS A 451
LEU A 467
THR A 493
ASP A 561
PHE A 562
 None
 0.79A 4xv2B-2qr7A:
20.0		 4xv2B-2qr7A:
25.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2w4k DEATH-ASSOCIATED
PROTEIN KINASE 1

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  40
LYS A  42
LEU A  68
ASP A 161
PHE A 162
 ADP  A1303 (-3.5A)
ADP  A1303 (-2.7A)
None
MG  A1304 ( 2.8A)
None
 0.85A 4xv2B-2w4kA:
24.0		 4xv2B-2w4kA:
26.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wnt RIBOSOMAL PROTEIN S6
KINASE

(Homo sapiens) 		PF00069
(Pkinase) 		6 ALA A 445
LYS A 447
LEU A 463
THR A 489
ASP A 557
PHE A 558
 None
 0.98A 4xv2B-2wntA:
20.6		 4xv2B-2wntA:
26.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yab DEATH-ASSOCIATED
PROTEIN KINASE 2

(Mus musculus) 		PF00069
(Pkinase) 		5 ALA A  40
LYS A  42
LEU A  68
ASP A 161
PHE A 162
 AMP  A1302 (-3.6A)
AMP  A1302 (-2.8A)
None
AMP  A1302 (-3.1A)
None
 0.81A 4xv2B-2yabA:
24.2		 4xv2B-2yabA:
25.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z2w WEE1-LIKE PROTEIN
KINASE

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A 326
CYH A 379
PHE A 433
GLY A 462
ASP A 463
 770  A 901 (-3.5A)
770  A 901 (-3.9A)
770  A 901 (-4.0A)
None
770  A 901 (-3.8A)
 0.62A 4xv2B-2z2wA:
23.1		 4xv2B-2z2wA:
27.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2z8c INSULIN RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A1028
LYS A1030
GLY A1149
ASP A1150
PHE A1151
 S91  A   1 (-3.2A)
S91  A   1 ( 4.2A)
None
None
None
 0.70A 4xv2B-2z8cA:
27.3		 4xv2B-2z8cA:
30.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bqr DEATH-ASSOCIATED
PROTEIN KINASE 3

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  40
LYS A  42
LEU A  68
ASP A 161
PHE A 162
 4RB  A 401 (-3.3A)
4RB  A 401 ( 2.8A)
None
GOL  A 503 ( 3.1A)
None
 0.76A 4xv2B-3bqrA:
22.7		 4xv2B-3bqrA:
28.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3d7u TYROSINE-PROTEIN
KINASE CSK

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 220
LYS A 222
THR A 266
ASP A 332
PHE A 333
 None
 0.88A 4xv2B-3d7uA:
28.4		 4xv2B-3d7uA:
30.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3f2a PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE PIM-1

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  65
LYS A  67
LEU A  93
ASP A 186
PHE A 187
 985  A   1 (-3.5A)
985  A   1 ( 2.8A)
MG  A 314 ( 4.8A)
985  A   1 ( 4.0A)
None
 0.78A 4xv2B-3f2aA:
18.1		 4xv2B-3f2aA:
25.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3kul EPHRIN TYPE-A
RECEPTOR 8

(Homo sapiens) 		PF07714
(Pkinase_Tyr)
PF14575
(EphA2_TM) 		5 ALA A 665
LYS A 667
THR A 713
ASP A 778
PHE A 779
 None
 0.72A 4xv2B-3kulA:
23.0		 4xv2B-3kulA:
32.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lij CALCIUM/CALMODULIN
DEPENDENT PROTEIN
KINASE WITH A KINASE
DOMAIN AND 4
CALMODULIN LIKE EF
HANDS

(Cryptosporidium
parvum) 		PF00069
(Pkinase)
PF13499
(EF-hand_7) 		5 ALA A  89
LYS A  91
LEU A 113
ASP A 205
PHE A 206
 ANP  A 522 (-3.6A)
ANP  A 522 (-3.5A)
None
MG  A 521 ( 3.6A)
None
 0.68A 4xv2B-3lijA:
25.3		 4xv2B-3lijA:
24.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lj0 SERINE/THREONINE-PRO
TEIN
KINASE/ENDORIBONUCLE
ASE IRE1

(Saccharomyces
cerevisiae) 		PF00069
(Pkinase)
PF06479
(Ribonuc_2-5A) 		5 ALA A 700
LYS A 702
CYH A 748
ASP A 828
PHE A 829
 ADP  A2101 (-3.5A)
ADP  A2101 (-2.7A)
ADP  A2101 (-4.2A)
SR  A2103 (-2.6A)
None
 0.68A 4xv2B-3lj0A:
23.8		 4xv2B-3lj0A:
24.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3llt SERINE/THREONINE
KINASE-1, PFLAMMER

(Plasmodium
falciparum) 		PF00069
(Pkinase) 		5 ALA A 579
LYS A 581
LEU A 600
ASP A 720
PHE A 721
 ANP  A 877 ( 3.7A)
ANP  A 877 (-2.7A)
None
ANP  A 877 (-2.9A)
None
 0.97A 4xv2B-3lltA:
21.7		 4xv2B-3lltA:
27.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mi9 CELL DIVISION
PROTEIN KINASE 9

(Homo sapiens) 		PF00069
(Pkinase) 		6 ALA A  46
LYS A  48
LEU A  70
CYH A 106
ASP A 167
PHE A 168
 None
 0.83A 4xv2B-3mi9A:
17.5		 4xv2B-3mi9A:
24.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mvj CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  70
LYS A  72
LEU A  95
ASP A 184
PHE A 185
 XFE  A 351 (-3.2A)
None
None
None
None
 0.97A 4xv2B-3mvjA:
22.0		 4xv2B-3mvjA:
27.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3omv RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		9 ALA A 373
LEU A 397
LEU A 406
THR A 421
TRP A 423
CYH A 424
PHE A 475
GLY A 485
PHE A 487
 SM5  A   1 (-3.6A)
None
None
SM5  A   1 (-4.4A)
SM5  A   1 (-4.3A)
SM5  A   1 ( 4.4A)
SM5  A   1 (-3.0A)
None
None
 0.77A 4xv2B-3omvA:
35.4		 4xv2B-3omvA:
72.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3omv RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		8 ALA A 373
LEU A 406
TRP A 423
CYH A 424
PHE A 475
GLY A 485
ASP A 486
PHE A 487
 SM5  A   1 (-3.6A)
None
SM5  A   1 (-4.3A)
SM5  A   1 ( 4.4A)
SM5  A   1 (-3.0A)
None
SM5  A   1 (-3.5A)
None
 0.99A 4xv2B-3omvA:
35.4		 4xv2B-3omvA:
72.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3omv RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		7 ALA A 373
LYS A 375
LEU A 397
THR A 421
PHE A 475
GLY A 485
PHE A 487
 SM5  A   1 (-3.6A)
SM5  A   1 (-3.5A)
None
SM5  A   1 (-4.4A)
SM5  A   1 (-3.0A)
None
None
 0.89A 4xv2B-3omvA:
35.4		 4xv2B-3omvA:
72.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ppz SERINE/THREONINE-PRO
TEIN KINASE CTR1

(Arabidopsis
thaliana) 		PF07714
(Pkinase_Tyr) 		5 ALA A 576
LYS A 578
THR A 625
ASP A 694
PHE A 695
 STU  A   1 (-3.3A)
STU  A   1 (-3.5A)
STU  A   1 (-4.1A)
STU  A   1 (-3.5A)
None
 0.85A 4xv2B-3ppzA:
29.7		 4xv2B-3ppzA:
38.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3q4t ACTIVIN RECEPTOR
TYPE-2A

(Homo sapiens) 		PF00069
(Pkinase) 		6 ALA A 217
LYS A 219
LEU A 247
THR A 267
ASP A 340
PHE A 341
 TAK  A   2 (-3.5A)
TAK  A   2 (-2.9A)
None
TAK  A   2 (-3.5A)
None
None
 0.79A 4xv2B-3q4tA:
25.5		 4xv2B-3q4tA:
30.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3q5i PROTEIN KINASE

(Plasmodium
berghei) 		PF00069
(Pkinase)
PF13499
(EF-hand_7) 		6 ALA A  84
LYS A  86
LEU A 119
THR A 144
ASP A 211
PHE A 212
 ANP  A1634 (-3.6A)
ANP  A1634 (-3.1A)
None
ANP  A1634 (-4.6A)
MG  A 529 (-2.2A)
None
 0.71A 4xv2B-3q5iA:
21.8		 4xv2B-3q5iA:
22.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3q60 ROP5B

(Toxoplasma
gondii) 		PF14531
(Kinase-like) 		5 ALA A 261
LEU A 304
PHE A 396
GLY A 406
ASP A 407
 ATP  A 600 (-3.6A)
ATP  A 600 ( 4.8A)
ATP  A 600 (-4.4A)
None
MG  A 602 ( 2.5A)
 0.96A 4xv2B-3q60A:
18.2		 4xv2B-3q60A:
23.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qd2 EUKARYOTIC
TRANSLATION
INITIATION FACTOR
2-ALPHA KINASE 3

(Mus musculus) 		PF00069
(Pkinase) 		7 ALA B 616
LYS B 618
CYH B 889
PHE B 942
GLY B 952
ASP B 953
PHE B 954
 None
 0.70A 4xv2B-3qd2B:
22.7		 4xv2B-3qd2B:
24.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qd2 EUKARYOTIC
TRANSLATION
INITIATION FACTOR
2-ALPHA KINASE 3

(Mus musculus) 		PF00069
(Pkinase) 		7 ALA B 616
LYS B 618
LEU B 639
PHE B 942
GLY B 952
ASP B 953
PHE B 954
 None
 0.83A 4xv2B-3qd2B:
22.7		 4xv2B-3qd2B:
24.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3s95 LIM DOMAIN KINASE 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 LYS A 368
LEU A 397
THR A 413
ASP A 478
PHE A 479
 STU  A   1 (-3.1A)
STU  A   1 (-4.6A)
STU  A   1 (-3.9A)
STU  A   1 ( 4.2A)
None
 0.84A 4xv2B-3s95A:
25.1		 4xv2B-3s95A:
29.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3zbf PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ROS

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 ALA A1978
LYS A1980
LEU A2010
GLY A2101
ASP A2102
PHE A2103
 VGH  A3000 (-3.4A)
VGH  A3000 ( 4.7A)
VGH  A3000 (-4.8A)
VGH  A3000 (-3.5A)
None
None
 0.80A 4xv2B-3zbfA:
28.3		 4xv2B-3zbfA:
31.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zdu CYCLIN-DEPENDENT
KINASE-LIKE 3

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  31
LYS A  33
LEU A  54
ASP A 143
PHE A 144
 38R  A 350 (-3.4A)
38R  A 350 (-2.9A)
None
NA  A 353 ( 2.5A)
None
 0.80A 4xv2B-3zduA:
23.1		 4xv2B-3zduA:
28.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3zfx EPHRIN TYPE-B
RECEPTOR 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 649
LYS A 651
THR A 697
ASP A 762
PHE A 763
 None
 0.70A 4xv2B-3zfxA:
28.4		 4xv2B-3zfxA:
32.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4a4l SERINE/THREONINE-PRO
TEIN KINASE PLK1

(Homo sapiens) 		PF00069
(Pkinase) 		7 ALA A  80
LYS A  82
CYH A 133
PHE A 183
GLY A 193
ASP A 194
PHE A 195
 939  A1331 (-3.5A)
939  A1331 (-2.6A)
939  A1331 (-4.0A)
939  A1331 (-4.0A)
None
939  A1331 (-3.1A)
None
 0.65A 4xv2B-4a4lA:
24.7		 4xv2B-4a4lA:
26.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4agu CYCLIN-DEPENDENT
KINASE-LIKE 1

(Homo sapiens) 		PF00069
(Pkinase) 		6 ALA A  31
LYS A  33
LEU A  55
CYH A  83
ASP A 144
PHE A 145
 D15  A 500 (-3.4A)
D15  A 500 ( 4.1A)
None
D15  A 500 (-4.3A)
D15  A 500 (-3.7A)
None
 1.02A 4xv2B-4aguA:
24.4		 4xv2B-4aguA:
23.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4at3 BDNF/NT-3 GROWTH
FACTORS RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 586
LEU A 608
GLY A 709
ASP A 710
PHE A 711
 LTI  A1839 (-3.3A)
None
LTI  A1839 (-3.4A)
None
None
 0.84A 4xv2B-4at3A:
27.9		 4xv2B-4at3A:
29.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4aw2 SERINE/THREONINE-PRO
TEIN KINASE MRCK
ALPHA

(Rattus
norvegicus) 		PF00069
(Pkinase)
PF00433
(Pkinase_C) 		5 ALA A 104
LYS A 106
LEU A 129
ASP A 219
PHE A 220
 EDO  A1420 (-3.4A)
EDO  A1419 (-3.3A)
None
None
None
 0.87A 4xv2B-4aw2A:
20.2		 4xv2B-4aw2A:
21.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4aw5 EPHRIN TYPE-B
RECEPTOR 4

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 121
LYS A 123
THR A 169
ASP A 234
PHE A 235
 30K  A1365 (-3.2A)
30K  A1365 (-3.8A)
30K  A1365 (-3.8A)
30K  A1365 (-3.3A)
None
 0.89A 4xv2B-4aw5A:
28.4		 4xv2B-4aw5A:
32.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4b6l SERINE/THREONINE-PRO
TEIN KINASE PLK3

(Homo sapiens) 		PF00069
(Pkinase) 		7 ALA A  89
LYS A  91
CYH A 142
PHE A 192
GLY A 202
ASP A 203
PHE A 204
 9ZP  A1333 (-3.5A)
None
9ZP  A1333 (-4.1A)
9ZP  A1333 (-3.6A)
9ZP  A1333 ( 4.4A)
None
None
 0.72A 4xv2B-4b6lA:
24.5		 4xv2B-4b6lA:
28.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4c0t LIKELY PROTEIN
KINASE

(Candida
albicans) 		PF00069
(Pkinase) 		5 ALA A 267
LYS A 269
LEU A 292
ASP A 382
PHE A 383
 None
 0.91A 4xv2B-4c0tA:
22.5		 4xv2B-4c0tA:
14.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4e93 TYROSINE-PROTEIN
KINASE FES/FPS

(Homo sapiens) 		PF00017
(SH2)
PF07714
(Pkinase_Tyr) 		5 ALA A 588
LYS A 590
LEU A 611
ASP A 701
PHE A 702
 GUI  A 901 (-3.4A)
GUI  A 901 (-2.8A)
None
GUI  A 901 ( 4.1A)
None
 0.96A 4xv2B-4e93A:
29.5		 4xv2B-4e93A:
26.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4eut SERINE/THREONINE-PRO
TEIN KINASE TBK1

(Homo sapiens) 		PF00069
(Pkinase) 		6 ALA A  36
LYS A  38
LEU A  59
CYH A  89
ASP A 157
PHE A 158
 BX7  A 401 (-3.4A)
BX7  A 401 ( 4.0A)
None
BX7  A 401 (-4.1A)
BX7  A 401 ( 3.7A)
None
 0.66A 4xv2B-4eutA:
21.1		 4xv2B-4eutA:
24.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1

(Homo sapiens) 		PF00069
(Pkinase) 		6 ALA A  36
LYS A  38
LEU A  59
CYH A  89
ASP A 157
PHE A 158
 BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
BX7  A 401 (-4.1A)
BX7  A 401 (-3.6A)
None
 0.77A 4xv2B-4euuA:
23.4		 4xv2B-4euuA:
26.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ez5 CYCLIN-DEPENDENT
KINASE 6

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  41
LYS A  43
LEU A  65
ASP A 163
PHE A 164
 0RS  A 900 ( 3.7A)
0RS  A 900 (-3.3A)
None
0RS  A 900 (-3.6A)
None
 0.89A 4xv2B-4ez5A:
24.0		 4xv2B-4ez5A:
27.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4f99 CELL DIVISION CYCLE
7-RELATED PROTEIN
KINASE

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  88
LYS A  90
LEU A 108
ASP A 196
PHE A 197
 ADP  A 601 (-3.5A)
ADP  A 601 (-2.6A)
None
MG  A 602 ( 3.1A)
None
 0.93A 4xv2B-4f99A:
15.8		 4xv2B-4f99A:
24.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fod ALK TYROSINE KINASE
RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A1148
LYS A1150
GLY A1269
ASP A1270
PHE A1271
 0UV  A1501 (-3.4A)
0UV  A1501 (-3.7A)
0UV  A1501 (-4.5A)
0UV  A1501 ( 4.2A)
None
 0.80A 4xv2B-4fodA:
27.1		 4xv2B-4fodA:
28.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4gl9 TYROSINE-PROTEIN
KINASE

(Mus musculus) 		PF07714
(Pkinase_Tyr) 		5 ALA A 880
LYS A 882
GLY A 993
ASP A 994
PHE A 995
 IZA  A2001 (-3.4A)
IZA  A2001 ( 4.7A)
None
IZA  A2001 ( 4.5A)
None
 0.90A 4xv2B-4gl9A:
17.6		 4xv2B-4gl9A:
30.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4i6f SERINE/THREONINE-PRO
TEIN KINASE PLK2

(Homo sapiens) 		PF00069
(Pkinase) 		7 ALA A 109
LYS A 111
CYH A 162
PHE A 212
GLY A 222
ASP A 223
PHE A 224
 1C7  A 401 (-3.2A)
1C7  A 401 ( 4.7A)
1C7  A 401 (-4.1A)
1C7  A 401 (-4.0A)
None
None
None
 0.72A 4xv2B-4i6fA:
23.0		 4xv2B-4i6fA:
28.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4id7 ACTIVATED CDC42
KINASE 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 ALA A 156
LYS A 158
THR A 205
GLY A 269
ASP A 270
PHE A 271
 1G0  A 401 (-3.6A)
1G0  A 401 (-3.7A)
1G0  A 401 (-3.2A)
None
None
1G0  A 401 ( 4.8A)
 1.19A 4xv2B-4id7A:
27.3		 4xv2B-4id7A:
29.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4j7b POLO-LIKE KINASE

(Danio rerio) 		PF00069
(Pkinase) 		7 ALA A  66
LYS A  68
CYH A 119
PHE A 169
GLY A 179
ASP A 180
PHE A 181
 None
 0.71A 4xv2B-4j7bA:
24.5		 4xv2B-4j7bA:
27.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mvf CALCIUM-DEPENDENT
PROTEIN KINASE 2

(Plasmodium
falciparum) 		PF00069
(Pkinase)
PF13499
(EF-hand_7) 		5 ALA A  99
LYS A 101
CYH A 149
ASP A 213
PHE A 214
 STU  A 601 (-3.3A)
STU  A 601 (-3.9A)
STU  A 601 (-4.2A)
STU  A 601 (-4.3A)
None
 0.86A 4xv2B-4mvfA:
21.7		 4xv2B-4mvfA:
22.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4o1o RIBONUCLEASE L

(Sus scrofa) 		PF00069
(Pkinase)
PF06479
(Ribonuc_2-5A)
PF12796
(Ank_2)
PF13857
(Ank_5) 		5 ALA A 388
LYS A 390
CYH A 435
ASP A 500
PHE A 501
 None
 0.85A 4xv2B-4o1oA:
16.1		 4xv2B-4o1oA:
17.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4o1o RIBONUCLEASE L

(Sus scrofa) 		PF00069
(Pkinase)
PF06479
(Ribonuc_2-5A)
PF12796
(Ank_2)
PF13857
(Ank_5) 		5 ALA A 388
LYS A 390
LEU A 406
CYH A 435
PHE A 501
 None
 0.78A 4xv2B-4o1oA:
16.1		 4xv2B-4o1oA:
17.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4o38 CYCLIN-G-ASSOCIATED
KINASE

(Homo sapiens) 		PF00069
(Pkinase) 		6 ALA A  67
LYS A  69
THR A 123
CYH A 126
ASP A 191
PHE A 192
 SIN  A 401 ( 3.7A)
None
None
SIN  A 401 (-4.3A)
None
None
 0.71A 4xv2B-4o38A:
21.0		 4xv2B-4o38A:
26.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4oav PROTEIN (RNASE L)

(Homo sapiens) 		PF00069
(Pkinase)
PF06479
(Ribonuc_2-5A)
PF12796
(Ank_2)
PF13857
(Ank_5) 		6 ALA B 390
LYS B 392
LEU B 408
CYH B 437
ASP B 503
PHE B 504
 ACP  B 801 (-3.2A)
ACP  B 801 (-2.8A)
None
ACP  B 801 (-4.5A)
MG  B 803 (-1.8A)
None
 0.89A 4xv2B-4oavB:
17.2		 4xv2B-4oavB:
18.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4oli NON-RECEPTOR
TYROSINE-PROTEIN
KINASE TYK2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 928
LEU A 951
GLY A1040
ASP A1041
PHE A1042
 2TT  A1202 ( 3.9A)
None
2TT  A1202 (-3.4A)
2TT  A1202 (-4.6A)
None
 0.96A 4xv2B-4oliA:
27.0		 4xv2B-4oliA:
19.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ylj DUAL SPECIFICITY
TYROSINE-PHOSPHORYLA
TION-REGULATED
KINASE 1A

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A 186
LYS A 188
LEU A 207
ASP A 307
PHE A 308
 4E1  A 505 (-3.5A)
4E1  A 505 (-2.7A)
None
4E1  A 505 (-3.6A)
None
 0.80A 4xv2B-4yljA:
21.3		 4xv2B-4yljA:
28.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ysj CALMODULIN-LIKE
DOMAIN PROTEIN
KINASE

(Eimeria tenella) 		PF00069
(Pkinase)
PF13499
(EF-hand_7) 		6 ALA A  55
LYS A  57
LEU A  80
THR A 105
ASP A 172
PHE A 173
 ADP  A 506 (-3.3A)
ADP  A 506 (-2.4A)
None
ADP  A 506 ( 4.6A)
ADP  A 506 ( 2.4A)
None
 0.85A 4xv2B-4ysjA:
25.0		 4xv2B-4ysjA:
22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e8y TGF-BETA RECEPTOR
TYPE-2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 ALA A 275
LYS A 277
LEU A 305
THR A 325
ASP A 397
PHE A 398
 STU  A 601 (-3.1A)
STU  A 601 (-2.4A)
STU  A 601 ( 3.8A)
STU  A 601 ( 3.7A)
STU  A 601 (-3.0A)
None
 0.59A 4xv2B-5e8yA:
25.2		 4xv2B-5e8yA:
28.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ezr CGMP-DEPENDENT
PROTEIN KINASE,
PUTATIVE

(Plasmodium
vivax) 		PF00027
(cNMP_binding)
PF00069
(Pkinase) 		5 ALA A 561
LYS A 563
THR A 611
ASP A 675
PHE A 676
 4ZS  A 901 ( 3.8A)
4ZS  A 901 (-3.9A)
4ZS  A 901 (-3.2A)
None
4ZS  A 901 (-4.9A)
 0.85A 4xv2B-5ezrA:
19.7		 4xv2B-5ezrA:
17.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5f1z NON-RECEPTOR
TYROSINE-PROTEIN
KINASE TYK2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 928
LYS A 930
GLY A1040
ASP A1041
PHE A1042
 5U3  A1200 (-3.5A)
None
5U3  A1200 ( 4.9A)
5U3  A1200 ( 4.9A)
None
 0.72A 4xv2B-5f1zA:
26.7		 4xv2B-5f1zA:
28.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5fd2 SERINE/THREONINE-PRO
TEIN KINASE B-RAF

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		10 ALA A 481
LYS A 483
LEU A 505
LEU A 514
THR A 529
TRP A 531
CYH A 532
PHE A 583
GLY A 593
PHE A 595
 5XJ  A 801 (-3.1A)
5XJ  A 801 (-3.8A)
5XJ  A 801 (-3.8A)
5XJ  A 801 (-4.5A)
5XJ  A 801 (-3.4A)
5XJ  A 801 (-4.4A)
5XJ  A 801 (-4.6A)
5XJ  A 801 (-4.3A)
5XJ  A 801 ( 3.7A)
5XJ  A 801 (-3.7A)
 0.76A 4xv2B-5fd2A:
36.1		 4xv2B-5fd2A:
90.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5fd2 SERINE/THREONINE-PRO
TEIN KINASE B-RAF

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		10 ALA A 481
LYS A 483
LEU A 505
LEU A 514
THR A 529
TRP A 531
PHE A 583
GLY A 593
ASP A 594
PHE A 595
 5XJ  A 801 (-3.1A)
5XJ  A 801 (-3.8A)
5XJ  A 801 (-3.8A)
5XJ  A 801 (-4.5A)
5XJ  A 801 (-3.4A)
5XJ  A 801 (-4.4A)
5XJ  A 801 (-4.3A)
5XJ  A 801 ( 3.7A)
None
5XJ  A 801 (-3.7A)
 0.80A 4xv2B-5fd2A:
36.1		 4xv2B-5fd2A:
90.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5hes MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE MLT

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A  43
LYS A  45
LEU A  57
THR A  82
ASP A 151
 032  A 401 (-3.2A)
032  A 401 (-4.4A)
032  A 401 ( 4.7A)
032  A 401 (-3.7A)
032  A 401 (-4.6A)
 0.64A 4xv2B-5hesA:
7.5		 4xv2B-5hesA:
31.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5iso 5'-AMP-ACTIVATED
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA-2

(Homo sapiens) 		PF00069
(Pkinase)
PF16579
(AdenylateSensor) 		5 ALA A  43
LYS A  45
LEU A  68
ASP A 157
PHE A 158
 STU  A 601 (-3.3A)
STU  A 601 ( 4.4A)
None
STU  A 601 (-3.5A)
None
 0.84A 4xv2B-5isoA:
25.7		 4xv2B-5isoA:
21.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j5t MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE KINASE
3

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  43
LYS A  45
CYH A  93
ASP A 154
PHE A 155
 6G2  A 901 (-3.2A)
6G2  A 901 ( 3.9A)
TPO  A 145 (-4.1A)
6G2  A 901 (-3.4A)
None
 0.71A 4xv2B-5j5tA:
22.7		 4xv2B-5j5tA:
25.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jzn SERINE/THREONINE-PRO
TEIN KINASE DCLK1

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A 417
LYS A 419
GLY A 532
ASP A 533
PHE A 534
 GUI  A 701 ( 3.9A)
GUI  A 701 (-3.1A)
GUI  A 701 ( 4.7A)
GUI  A 701 ( 4.8A)
None
 0.80A 4xv2B-5jznA:
23.5		 4xv2B-5jznA:
26.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jzn SERINE/THREONINE-PRO
TEIN KINASE DCLK1

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A 417
LYS A 419
LEU A 440
GLY A 532
PHE A 534
 GUI  A 701 ( 3.9A)
GUI  A 701 (-3.1A)
None
GUI  A 701 ( 4.7A)
None
 0.79A 4xv2B-5jznA:
23.5		 4xv2B-5jznA:
26.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ko1 MIXED LINEAGE KINASE
DOMAIN-LIKE PROTEIN

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 228
LYS A 230
LEU A 263
CYH A 286
PHE A 350
 6UY  A 501 (-3.4A)
6UY  A 501 (-4.0A)
None
6UY  A 501 (-4.3A)
None
 0.78A 4xv2B-5ko1A:
26.1		 4xv2B-5ko1A:
26.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lxd DUAL SPECIFICITY
TYROSINE-PHOSPHORYLA
TION-REGULATED
KINASE 2

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A 176
LYS A 178
LEU A 197
ASP A 295
PHE A 296
 7A7  A 501 (-3.5A)
7A7  A 501 (-3.5A)
None
7A7  A 501 (-3.2A)
None
 0.95A 4xv2B-5lxdA:
20.5		 4xv2B-5lxdA:
25.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5o2c SERINE/THREONINE-PRO
TEIN KINASE WNK3

(Homo sapiens) 		PF00069
(Pkinase)
PF12202
(OSR1_C) 		5 ALA A 174
LEU A 198
THR A 227
PHE A 282
GLY A 293
 GOL  A 604 ( 3.8A)
None
GOL  A 604 (-3.9A)
GOL  A 604 ( 4.5A)
GOL  A 604 ( 4.6A)
 0.53A 4xv2B-5o2cA:
25.9		 4xv2B-5o2cA:
28.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tur SERINE/THREONINE-PRO
TEIN KINASE PIM-1

(Homo sapiens) 		no annotation 5 ALA A  65
LYS A  67
LEU A  93
ASP A 186
PHE A 187
 7LK  A 401 (-3.3A)
None
None
None
None
 0.82A 4xv2B-5turA:
22.9		 4xv2B-5turA:
22.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tvt MATERNAL EMBRYONIC
LEUCINE ZIPPER
KINASE

(Homo sapiens) 		no annotation 5 ALA A  38
LYS A  40
CYH A  89
ASP A 150
PHE A 151
 7LV  A 401 (-3.4A)
7LV  A 401 (-3.0A)
7LV  A 401 (-4.3A)
7LV  A 401 (-4.2A)
None
 0.80A 4xv2B-5tvtA:
23.6		 4xv2B-5tvtA:
27.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vcx MEMBRANE-ASSOCIATED
TYROSINE- AND
THREONINE-SPECIFIC
CDC2-INHIBITORY
KINASE

(Homo sapiens) 		PF00069
(Pkinase) 		6 ALA A 137
THR A 187
CYH A 190
PHE A 240
GLY A 250
ASP A 251
 H8H  A 401 (-3.3A)
H8H  A 401 (-3.5A)
H8H  A 401 (-4.3A)
H8H  A 401 (-4.3A)
None
EDO  A 402 ( 2.9A)
 0.67A 4xv2B-5vcxA:
22.6		 4xv2B-5vcxA:
25.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vcx MEMBRANE-ASSOCIATED
TYROSINE- AND
THREONINE-SPECIFIC
CDC2-INHIBITORY
KINASE

(Homo sapiens) 		PF00069
(Pkinase) 		6 ALA A 137
THR A 187
PHE A 240
GLY A 250
ASP A 251
PHE A 252
 H8H  A 401 (-3.3A)
H8H  A 401 (-3.5A)
H8H  A 401 (-4.3A)
None
EDO  A 402 ( 2.9A)
None
 0.65A 4xv2B-5vcxA:
22.6		 4xv2B-5vcxA:
25.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vdk WEE1-LIKE PROTEIN
KINASE 2

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A 239
CYH A 292
PHE A 346
GLY A 379
ASP A 380
 8X7  A 501 ( 3.7A)
8X7  A 501 (-3.8A)
8X7  A 501 (-3.7A)
None
8X7  A 501 (-4.8A)
 0.74A 4xv2B-5vdkA:
22.8		 4xv2B-5vdkA:
27.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5vo1 MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 12

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 150
LYS A 152
CYH A 193
ASP A 254
PHE A 255
 9FS  A 501 (-3.4A)
None
9FS  A 501 (-4.3A)
None
None
 0.92A 4xv2B-5vo1A:
27.3		 4xv2B-5vo1A:
36.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5y86 DUAL SPECIFICITY
TYROSINE-PHOSPHORYLA
TION-REGULATED
KINASE 3

(Homo sapiens) 		no annotation 5 ALA A 236
LYS A 238
LEU A 257
ASP A 355
PHE A 356
 HRM  A 601 (-3.5A)
HRM  A 601 (-3.3A)
None
HRM  A 601 (-4.7A)
None
 0.86A 4xv2B-5y86A:
20.8		 4xv2B-5y86A:
13.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6b3e CYCLIN-DEPENDENT
KINASE 12

(Homo sapiens) 		no annotation 5 ALA A 754
LYS A 756
LEU A 778
ASP A 877
PHE A 878
 CJM  A1102 (-3.1A)
None
None
MG  A1101 (-2.5A)
None
 0.69A 4xv2B-6b3eA:
24.1		 4xv2B-6b3eA:
16.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bfn INTERLEUKIN-1
RECEPTOR-ASSOCIATED
KINASE 1

(Homo sapiens) 		no annotation 5 ALA A 237
LYS A 239
GLY A 357
ASP A 358
PHE A 359
 DL1  A 601 (-3.4A)
DL1  A 601 ( 4.1A)
DL1  A 601 ( 4.8A)
DL1  A 601 (-3.1A)
None
 0.96A 4xv2B-6bfnA:
24.8		 4xv2B-6bfnA:
14.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c7y TYROSINE-PROTEIN
KINASE JAK1

(Homo sapiens) 		no annotation 6 ALA A 906
LYS A 908
LEU A 929
GLY A1020
ASP A1021
PHE A1022
 ADP  A1201 (-3.4A)
ADP  A1201 (-2.8A)
None
None
MG  A1203 (-1.8A)
None
 1.02A 4xv2B-6c7yA:
17.3		 4xv2B-6c7yA:
18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2

(Homo sapiens) 		no annotation 5 ALA A 191
LYS A 193
LEU A 212
ASP A 327
PHE A 328
 3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
None
3NG  A 501 (-4.5A)
None
 0.93A 4xv2B-6fylA:
22.2		 4xv2B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4

(Homo sapiens) 		no annotation 5 ALA A 189
LYS A 191
LEU A 210
ASP A 325
PHE A 326
 3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
None
3NG  A 501 (-4.3A)
None
 0.92A 4xv2B-6fyvA:
22.3		 4xv2B-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1dgm ADENOSINE KINASE

(Toxoplasma
gondii) 		PF00294
(PfkB) 		4 GLY A 280
VAL A 302
PHE A 324
ILE A 338
 None
 1.15A 4xv2B-1dgmA:
undetectable		 4xv2B-1dgmA:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1g61 TRANSLATION
INITIATION FACTOR 6

(Methanocaldococcus
jannaschii) 		PF01912
(eIF-6) 		4 GLY A2069
VAL A2064
PHE A2127
ILE A2100
 None
 1.03A 4xv2B-1g61A:
undetectable		 4xv2B-1g61A:
21.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1h2h HYPOTHETICAL PROTEIN
TM1643

(Thermotoga
maritima) 		PF01958
(DUF108)
PF03447
(NAD_binding_3) 		4 GLY A 174
VAL A 178
PHE A 206
ILE A 197
 None
 1.08A 4xv2B-1h2hA:
undetectable		 4xv2B-1h2hA:
19.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1h71 SERRALYSIN

(Pseudomonas sp.
'TAC II 18') 		PF00413
(Peptidase_M10)
PF08548
(Peptidase_M10_C) 		4 GLY P 376
VAL P 374
PHE P  14
ILE P 338
 None
 0.92A 4xv2B-1h71P:
0.0		 4xv2B-1h71P:
20.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1h79 ANAEROBIC
RIBONUCLEOTIDE-TRIPH
OSPHATE REDUCTASE
LARGE CHAIN

(Escherichia
virus T4) 		PF13597
(NRDD) 		4 GLY A 106
VAL A 171
PHE A 199
ILE A 214
 None
 1.07A 4xv2B-1h79A:
0.1		 4xv2B-1h79A:
17.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1l1f GLUTAMATE
DEHYDROGENASE 1

(Homo sapiens) 		PF00208
(ELFV_dehydrog)
PF02812
(ELFV_dehydrog_N) 		4 GLY A 260
VAL A 253
PHE A 298
ILE A 305
 None
 1.17A 4xv2B-1l1fA:
0.0		 4xv2B-1l1fA:
19.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1mg5 ALCOHOL
DEHYDROGENASE

(Drosophila
melanogaster) 		PF00106
(adh_short) 		4 GLY A 142
VAL A 160
PHE A 222
ILE A 137
 None
None
None
NAI  A 850 (-4.1A)
 1.08A 4xv2B-1mg5A:
0.6		 4xv2B-1mg5A:
20.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1n76 LACTOFERRIN

(Homo sapiens) 		PF00405
(Transferrin) 		4 GLY A 124
VAL A 127
PHE A 325
ILE A 328
 CO3  A 695 (-4.0A)
None
None
None
 1.14A 4xv2B-1n76A:
0.0		 4xv2B-1n76A:
16.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1oq1 PROTEIN YESU

(Bacillus
subtilis) 		PF09224
(DUF1961) 		4 GLY A 167
VAL A 169
PHE A  56
ILE A  60
 None
 1.15A 4xv2B-1oq1A:
undetectable		 4xv2B-1oq1A:
22.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1r8w GLYCEROL DEHYDRATASE

(Clostridium
butyricum) 		PF01228
(Gly_radical)
PF02901
(PFL-like) 		4 GLY A 254
VAL A 219
PHE A 267
ILE A 270
 None
 1.17A 4xv2B-1r8wA:
undetectable		 4xv2B-1r8wA:
16.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ru4 PECTATE LYASE

(Dickeya
chrysanthemi) 		PF13229
(Beta_helix) 		4 GLY A 281
VAL A 307
PHE A 236
ILE A 247
 None
 1.10A 4xv2B-1ru4A:
undetectable		 4xv2B-1ru4A:
20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1s4f RNA-DEPENDENT RNA
POLYMERASE

(Pestivirus A) 		PF00998
(RdRP_3) 		4 GLY A 459
VAL A 487
PHE A 491
ILE A 494
 None
 1.05A 4xv2B-1s4fA:
undetectable		 4xv2B-1s4fA:
18.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1uek 4-(CYTIDINE
5'-DIPHOSPHO)-2C-MET
HYL-D-ERYTHRITOL
KINASE

(Thermus
thermophilus) 		PF00288
(GHMP_kinases_N)
PF08544
(GHMP_kinases_C) 		4 GLY A  75
VAL A  44
PHE A  50
ILE A  79
 None
 1.11A 4xv2B-1uekA:
undetectable		 4xv2B-1uekA:
22.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vbl PECTATE LYASE 47

(Bacillus sp.
TS-47) 		PF00544
(Pec_lyase_C) 		4 GLY A  65
VAL A 139
PHE A  33
ILE A  61
 None
 1.12A 4xv2B-1vblA:
undetectable		 4xv2B-1vblA:
21.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vqv THIAMINE
MONOPHOSPHATE KINASE

(Aquifex
aeolicus) 		PF00586
(AIRS) 		4 GLY A 134
VAL A  72
PHE A 110
ILE A 192
 None
 0.94A 4xv2B-1vqvA:
undetectable		 4xv2B-1vqvA:
22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wvg CDP-GLUCOSE
4,6-DEHYDRATASE

(Salmonella
enterica) 		PF16363
(GDP_Man_Dehyd) 		4 GLY A 124
VAL A 188
PHE A  87
ILE A  85
 None
 1.14A 4xv2B-1wvgA:
undetectable		 4xv2B-1wvgA:
22.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1x5n HARMONIN

(Homo sapiens) 		PF00595
(PDZ) 		4 GLY A 100
VAL A  96
PHE A  73
ILE A  65
 None
 1.03A 4xv2B-1x5nA:
undetectable		 4xv2B-1x5nA:
17.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ywf PHOSPHOTYROSINE
PROTEIN PHOSPHATASE
PTPB

(Mycobacterium
tuberculosis) 		PF13350
(Y_phosphatase3) 		4 GLY A  67
VAL A  75
PHE A  28
ILE A  49
 None
 0.88A 4xv2B-1ywfA:
undetectable		 4xv2B-1ywfA:
23.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zov MONOMERIC SARCOSINE
OXIDASE

(Bacillus sp.
NS-129) 		PF01266
(DAO) 		4 GLY A 312
VAL A 224
PHE A 297
ILE A 266
 None
 1.17A 4xv2B-1zovA:
undetectable		 4xv2B-1zovA:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ae6 ACETYLTRANSFERASE,
GNAT FAMILY

(Enterococcus
faecalis) 		PF00583
(Acetyltransf_1) 		4 GLY A  94
VAL A  86
PHE A  53
ILE A  65
 None
 1.17A 4xv2B-2ae6A:
undetectable		 4xv2B-2ae6A:
20.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bfw GLGA GLYCOGEN
SYNTHASE

(Pyrococcus
abyssi) 		PF00534
(Glycos_transf_1) 		4 GLY A 256
VAL A 265
PHE A 252
ILE A 333
 SO4  A1417 ( 2.6A)
None
None
None
 1.15A 4xv2B-2bfwA:
undetectable		 4xv2B-2bfwA:
24.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2eo0 HYPOTHETICAL PROTEIN
ST1444

(Sulfurisphaera
tokodaii) 		PF01870
(Hjc) 		4 GLY A  26
VAL A  29
PHE A  90
ILE A  55
 None
 1.12A 4xv2B-2eo0A:
undetectable		 4xv2B-2eo0A:
19.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hu9 MERCURIC TRANSPORT
PROTEIN PERIPLASMIC
COMPONENT

(Archaeoglobus
fulgidus) 		no annotation 4 GLY A 104
VAL A  80
PHE A  92
ILE A 100
 FES  A 131 (-3.5A)
None
None
None
 1.16A 4xv2B-2hu9A:
undetectable		 4xv2B-2hu9A:
17.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ify 2,3-BISPHOSPHOGLYCER
ATE-INDEPENDENT
PHOSPHOGLYCERATE
MUTASE

(Bacillus
anthracis) 		PF01676
(Metalloenzyme)
PF06415
(iPGM_N) 		4 GLY A  59
VAL A  51
PHE A 343
ILE A  68
 None
 0.91A 4xv2B-2ifyA:
undetectable		 4xv2B-2ifyA:
20.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ly3 TRANSLOCATION AND
ASSEMBLY MODULE TAMA

(Escherichia
coli) 		PF17243
(POTRA_TamA_1) 		4 GLY 1  68
VAL 1  39
PHE 1  57
ILE 1  46
 None
 1.16A 4xv2B-2ly31:
undetectable		 4xv2B-2ly31:
13.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rjt BETA-KETOACYL-ACP
SYNTHASE II

(Streptococcus
pneumoniae) 		PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C) 		4 GLY A 228
VAL A 230
PHE A  46
ILE A 200
 None
 1.16A 4xv2B-2rjtA:
undetectable		 4xv2B-2rjtA:
21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ucz UBIQUITIN
CONJUGATING ENZYME

(Saccharomyces
cerevisiae) 		PF00179
(UQ_con) 		4 GLY A  27
VAL A  25
PHE A  54
ILE A  41
 None
 1.09A 4xv2B-2uczA:
undetectable		 4xv2B-2uczA:
19.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vqa SLL1358 PROTEIN

(Synechocystis
sp. PCC 6803) 		PF00190
(Cupin_1) 		4 GLY A 321
VAL A 294
PHE A 388
ILE A 272
 None
 0.90A 4xv2B-2vqaA:
undetectable		 4xv2B-2vqaA:
22.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vug PAB1020

(Pyrococcus
abyssi) 		PF09414
(RNA_ligase) 		4 GLY A  80
VAL A 240
PHE A 203
ILE A 229
 None
 0.89A 4xv2B-2vugA:
undetectable		 4xv2B-2vugA:
22.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yev CYTOCHROME C OXIDASE
POLYPEPTIDE I+III
CYTOCHROME C OXIDASE
SUBUNIT 2

(Thermus
thermophilus) 		PF00034
(Cytochrom_C)
PF00115
(COX1)
PF00116
(COX2)
PF00510
(COX3)
PF02790
(COX2_TM) 		4 GLY B 195
VAL B  22
PHE A 376
ILE B  24
 None
 1.16A 4xv2B-2yevB:
undetectable		 4xv2B-2yevB:
21.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zqp PREPROTEIN
TRANSLOCASE SECY
SUBUNIT

(Thermus
thermophilus) 		PF00344
(SecY) 		4 GLY Y  38
VAL Y 157
PHE Y  73
ILE Y  72
 None
 0.78A 4xv2B-2zqpY:
undetectable		 4xv2B-2zqpY:
18.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3a8p T-LYMPHOMA INVASION
AND
METASTASIS-INDUCING
PROTEIN 2

(Mus musculus) 		PF00169
(PH) 		4 GLY A 593
VAL A 595
PHE A 690
ILE A 572
 None
 1.17A 4xv2B-3a8pA:
undetectable		 4xv2B-3a8pA:
23.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3act CELLOBIOSE
PHOSPHORYLASE

(Cellulomonas
gilvus) 		PF06165
(Glyco_transf_36)
PF17167
(Glyco_hydro_36) 		4 GLY A 171
VAL A 173
PHE A 217
ILE A 246
 None
 1.04A 4xv2B-3actA:
undetectable		 4xv2B-3actA:
16.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3act CELLOBIOSE
PHOSPHORYLASE

(Cellulomonas
gilvus) 		PF06165
(Glyco_transf_36)
PF17167
(Glyco_hydro_36) 		4 GLY A 242
VAL A 173
PHE A 217
ILE A 246
 None
 1.08A 4xv2B-3actA:
undetectable		 4xv2B-3actA:
16.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c9r THIAMINE
MONOPHOSPHATE KINASE

(Aquifex
aeolicus) 		PF00586
(AIRS) 		4 GLY A 134
VAL A  72
PHE A 110
ILE A 192
 None
 0.95A 4xv2B-3c9rA:
undetectable		 4xv2B-3c9rA:
21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3cps GLYCERALDEHYDE
3-PHOSPHATE
DEHYDROGENASE

(Cryptosporidium
parvum) 		PF00044
(Gp_dh_N)
PF02800
(Gp_dh_C) 		4 GLY A  78
VAL A  90
PHE A  70
ILE A  83
 None
 1.01A 4xv2B-3cpsA:
undetectable		 4xv2B-3cpsA:
22.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3h39 TRNA NUCLEOTIDYL
TRANSFERASE-RELATED
PROTEIN

(Thermotoga
maritima) 		PF01743
(PolyA_pol)
PF12627
(PolyA_pol_RNAbd) 		4 GLY A  41
VAL A  39
PHE A   4
ILE A 149
 ATP  A 501 (-3.3A)
None
None
None
 1.15A 4xv2B-3h39A:
undetectable		 4xv2B-3h39A:
22.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hc7 GENE 12 PROTEIN

(Mycobacterium
virus D29) 		PF01083
(Cutinase) 		4 GLY A  89
VAL A  57
PHE A 106
ILE A  64
 None
 1.11A 4xv2B-3hc7A:
undetectable		 4xv2B-3hc7A:
23.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hgo 12-OXOPHYTODIENOATE
REDUCTASE 3

(Solanum
lycopersicum) 		PF00724
(Oxidored_FMN) 		4 GLY A 327
VAL A 331
PHE A  59
ILE A 317
 None
 1.17A 4xv2B-3hgoA:
undetectable		 4xv2B-3hgoA:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3l01 GLGA GLYCOGEN
SYNTHASE

(Pyrococcus
abyssi) 		PF00534
(Glycos_transf_1)
PF08323
(Glyco_transf_5) 		4 GLY A 256
VAL A 265
PHE A 252
ILE A 333
 None
 1.14A 4xv2B-3l01A:
undetectable		 4xv2B-3l01A:
22.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3omv RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		4 GLY A 358
VAL A 363
PHE A 408
ILE A 419
 None
SM5  A   1 (-4.0A)
None
SM5  A   1 ( 4.3A)
 0.44A 4xv2B-3omvA:
35.4		 4xv2B-3omvA:
72.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qde CELLOBIOSE
PHOSPHORYLASE

(Ruminiclostridium
thermocellum) 		PF06165
(Glyco_transf_36)
PF17167
(Glyco_hydro_36) 		4 GLY A 171
VAL A 173
PHE A 212
ILE A 241
 None
 1.11A 4xv2B-3qdeA:
undetectable		 4xv2B-3qdeA:
16.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qde CELLOBIOSE
PHOSPHORYLASE

(Ruminiclostridium
thermocellum) 		PF06165
(Glyco_transf_36)
PF17167
(Glyco_hydro_36) 		4 GLY A 237
VAL A 173
PHE A 212
ILE A 241
 None
 1.14A 4xv2B-3qdeA:
undetectable		 4xv2B-3qdeA:
16.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rru TOM1L1 PROTEIN

(Homo sapiens) 		PF00790
(VHS) 		4 GLY A 129
VAL A 134
PHE A  96
ILE A  91
 None
 1.05A 4xv2B-3rruA:
undetectable		 4xv2B-3rruA:
21.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3s4d LACTOSE
PHOSPHORYLASE

(Cellulomonas
uda) 		PF06165
(Glyco_transf_36)
PF17167
(Glyco_hydro_36) 		4 GLY A 171
VAL A 173
PHE A 217
ILE A 246
 None
 1.14A 4xv2B-3s4dA:
undetectable		 4xv2B-3s4dA:
16.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3sxs CYTOPLASMIC
TYROSINE-PROTEIN
KINASE BMX

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		4 GLY A 426
VAL A 431
PHE A 475
ILE A 487
 PP2  A   1 ( 4.8A)
PP2  A   1 (-4.5A)
None
PP2  A   1 (-3.6A)
 0.47A 4xv2B-3sxsA:
28.2		 4xv2B-3sxsA:
29.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vb0 GLYOXALASE/BLEOMYCIN
RESISTANCE
PROTEIN/DIOXYGENASE

(Sphingomonas
wittichii) 		PF00903
(Glyoxalase) 		4 GLY A  30
VAL A  33
PHE A  11
ILE A  52
 None
 1.17A 4xv2B-3vb0A:
undetectable		 4xv2B-3vb0A:
21.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vi1 ALKALINE
METALLOPROTEINASE

(Pseudomonas
aeruginosa) 		PF08548
(Peptidase_M10_C)
PF13583
(Reprolysin_4) 		4 GLY A 379
VAL A 377
PHE A  12
ILE A 341
 None
 0.82A 4xv2B-3vi1A:
undetectable		 4xv2B-3vi1A:
18.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vta CUCUMISIN

(Cucumis melo) 		PF00082
(Peptidase_S8) 		4 GLY A 674
VAL A 708
PHE A 637
ILE A 725
 None
 1.07A 4xv2B-3vtaA:
undetectable		 4xv2B-3vtaA:
17.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4a3s 6-PHOSPHOFRUCTOKINAS
E

(Bacillus
subtilis) 		PF00365
(PFK) 		4 GLY A 268
VAL A 284
PHE A 135
ILE A 286
 None
 0.97A 4xv2B-4a3sA:
undetectable		 4xv2B-4a3sA:
21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4aw7 GH86A
BETA-PORPHYRANASE

(Bacteroides
plebeius) 		no annotation 4 GLY A 166
VAL A 164
PHE A 176
ILE A 120
 None
 0.91A 4xv2B-4aw7A:
2.2		 4xv2B-4aw7A:
18.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dqd EXTRACELLULAR
LIGAND-BINDING
RECEPTOR

(Rhodopseudomonas
palustris) 		PF13458
(Peripla_BP_6) 		4 GLY A 256
VAL A 225
PHE A 236
ILE A 240
 None
 1.06A 4xv2B-4dqdA:
undetectable		 4xv2B-4dqdA:
21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fn5 ELONGATION FACTOR G
1

(Pseudomonas
aeruginosa) 		PF00009
(GTP_EFTU)
PF00679
(EFG_C)
PF03144
(GTP_EFTU_D2)
PF03764
(EFG_IV)
PF14492
(EFG_II) 		4 GLY A 611
VAL A 499
PHE A 539
ILE A 520
 None
 1.13A 4xv2B-4fn5A:
undetectable		 4xv2B-4fn5A:
17.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g38 SULFITE REDUCTASE
[NADPH] HEMOPROTEIN
BETA-COMPONENT

(Escherichia
coli) 		PF01077
(NIR_SIR)
PF03460
(NIR_SIR_ferr) 		4 GLY A 351
VAL A 349
PHE A 390
ILE A 400
 None
 1.14A 4xv2B-4g38A:
undetectable		 4xv2B-4g38A:
18.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gl9 SUPPRESSOR OF
CYTOKINE SIGNALING
3,SUPPRESSOR OF
CYTOKINE SIGNALING
3,SUPPRESSOR OF
CYTOKINE SIGNALING
3,SUPPRESSOR OF
CYTOKINE SIGNALING 3

(Mus musculus) 		PF00017
(SH2) 		4 GLY E  53
VAL E  51
PHE E  46
ILE E  70
 None
 1.09A 4xv2B-4gl9E:
undetectable		 4xv2B-4gl9E:
20.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4h09 HYPOTHETICAL LEUCINE
RICH REPEAT PROTEIN

(Eubacterium
ventriosum) 		PF13306
(LRR_5) 		4 GLY A 243
VAL A 239
PHE A 301
ILE A 285
 None
None
None
EDO  A 510 (-4.6A)
 1.10A 4xv2B-4h09A:
undetectable		 4xv2B-4h09A:
19.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4he4 YELLOW FLUORESCENT
PROTEIN

(Phialidium sp.
SL-2003) 		PF01353
(GFP) 		4 GLY A  40
VAL A  42
PHE A 112
ILE A  12
 None
 0.86A 4xv2B-4he4A:
undetectable		 4xv2B-4he4A:
21.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hva CASPASE-6

(Homo sapiens) 		PF00656
(Peptidase_C14) 		4 GLY A 215
VAL A 212
PHE A 118
ILE A 160
 None
 1.08A 4xv2B-4hvaA:
undetectable		 4xv2B-4hvaA:
20.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hwg UDP-N-ACETYLGLUCOSAM
INE 2-EPIMERASE

(Rickettsia
bellii) 		PF02350
(Epimerase_2) 		4 GLY A 167
VAL A 354
PHE A 113
ILE A 361
 None
 0.81A 4xv2B-4hwgA:
undetectable		 4xv2B-4hwgA:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hyd PUTATIVE
UNCHARACTERIZED
PROTEIN

(Methanoculleus
marisnigri) 		PF06550
(SPP) 		4 GLY A 250
VAL A 228
PHE A  18
ILE A  21
 None
 0.91A 4xv2B-4hydA:
undetectable		 4xv2B-4hydA:
21.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4i4i 6-PHOSPHOFRUCTOKINAS
E

(Geobacillus
stearothermophilus) 		PF00365
(PFK) 		4 GLY A 268
VAL A 284
PHE A 135
ILE A 286
 None
 0.91A 4xv2B-4i4iA:
undetectable		 4xv2B-4i4iA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jnd CA(2+)/CALMODULIN-DE
PENDENT PROTEIN
KINASE PHOSPHATASE

(Caenorhabditis
elegans) 		PF00481
(PP2C) 		4 GLY A 422
VAL A 420
PHE A 376
ILE A 404
 None
 0.98A 4xv2B-4jndA:
undetectable		 4xv2B-4jndA:
22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4obu PYRIDOXAL-DEPENDENT
DECARBOXYLASE DOMAIN
PROTEIN

([Ruminococcus]
gnavus) 		no annotation 4 GLY E 159
VAL E 317
PHE E 271
ILE E 273
 PLP  E 501 (-3.5A)
None
None
None
 1.13A 4xv2B-4obuE:
1.8		 4xv2B-4obuE:
21.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4r1i AMINOBENZOYL-GLUTAMA
TE TRANSPORTER

(Neisseria
gonorrhoeae) 		PF03806
(ABG_transport) 		4 GLY A 198
VAL A  99
PHE A 188
ILE A 319
 None
 1.03A 4xv2B-4r1iA:
undetectable		 4xv2B-4r1iA:
20.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ra7 PEPTIDOGLYCAN
GLYCOSYLTRANSFERASE

(Atopobium
parvulum) 		PF00905
(Transpeptidase) 		4 GLY A 762
VAL A 827
PHE A 908
ILE A 821
 None
 1.17A 4xv2B-4ra7A:
undetectable		 4xv2B-4ra7A:
19.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rh7 GREEN FLUORESCENT
PROTEIN/CYTOPLASMIC
DYNEIN 2 HEAVY CHAIN
1

(Homo sapiens;
synthetic
construct) 		PF03028
(Dynein_heavy)
PF07728
(AAA_5)
PF08393
(DHC_N2)
PF12774
(AAA_6)
PF12775
(AAA_7)
PF12777
(MT)
PF12780
(AAA_8)
PF12781
(AAA_9) 		4 GLY A1984
VAL A2169
PHE A2421
ILE A2424
 ATP  A4403 (-2.9A)
None
None
None
 1.12A 4xv2B-4rh7A:
undetectable		 4xv2B-4rh7A:
6.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rld ASPARTIC PROTEASE
BLA G 2

(Blattella
germanica) 		PF00026
(Asp) 		4 GLY A  16
VAL A   4
PHE A 313
ILE A 153
 None
 1.00A 4xv2B-4rldA:
undetectable		 4xv2B-4rldA:
20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4tsh SURFACE PROTEIN
ADHESIN

(Streptococcus
mutans) 		PF16364
(Antigen_C) 		4 GLY B1398
VAL B1430
PHE B1385
ILE B1439
 None
 1.15A 4xv2B-4tshB:
undetectable		 4xv2B-4tshB:
19.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4u7d ATP-DEPENDENT DNA
HELICASE Q1

(Homo sapiens) 		PF00270
(DEAD)
PF00271
(Helicase_C)
PF16124
(RecQ_Zn_bind) 		4 GLY A 252
VAL A 109
PHE A  92
ILE A 100
 None
 1.03A 4xv2B-4u7dA:
undetectable		 4xv2B-4u7dA:
20.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4us4 TRANSPORTER

(Bacillus
halodurans) 		PF00209
(SNF) 		4 GLY A  94
VAL A 331
PHE A 230
ILE A 104
 None
None
TRP  A 601 (-4.4A)
None
 1.10A 4xv2B-4us4A:
0.9		 4xv2B-4us4A:
21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ywo MERCURIC REDUCTASE

(Metallosphaera
sedula) 		PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2) 		4 GLY A 273
VAL A 276
PHE A 126
ILE A 287
 None
 1.15A 4xv2B-4ywoA:
undetectable		 4xv2B-4ywoA:
23.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yxf MUPS

(Pseudomonas
fluorescens) 		PF13561
(adh_short_C2) 		4 GLY A 146
VAL A 148
PHE A  84
ILE A  25
 None
 1.03A 4xv2B-4yxfA:
undetectable		 4xv2B-4yxfA:
22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zj8 HUMAN OX1R FUSION
PROTEIN TO P.ABYSII
GLYCOGEN SYNTHASE

(Homo sapiens;
Pyrococcus
abyssi) 		PF00001
(7tm_1)
PF00534
(Glycos_transf_1) 		4 GLY A1039
VAL A1048
PHE A1035
ILE A1116
 None
 1.11A 4xv2B-4zj8A:
0.5		 4xv2B-4zj8A:
21.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zoh PUTATIVE
OXIDOREDUCTASE
MOLYBDOPTERIN-BINDIN
G SUBUNIT

(Sulfurisphaera
tokodaii) 		PF01315
(Ald_Xan_dh_C)
PF02738
(Ald_Xan_dh_C2) 		4 GLY A 137
VAL A 140
PHE A 262
ILE A 275
 None
 1.16A 4xv2B-4zohA:
undetectable		 4xv2B-4zohA:
17.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5aoh CARF

(Serratia sp.
ATCC 39006) 		PF03781
(FGE-sulfatase) 		4 GLY A  65
VAL A  87
PHE A 230
ILE A 257
 None
 1.13A 4xv2B-5aohA:
0.7		 4xv2B-5aohA:
21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5b23 UNCHARACTERIZED
PROTEIN SORTASE B

(Clostridium
perfringens) 		PF04203
(Sortase) 		4 GLY A  96
VAL A 119
PHE A  91
ILE A 117
 None
 1.13A 4xv2B-5b23A:
undetectable		 4xv2B-5b23A:
20.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5bnd ABC TRANSPORTER,
ATP-BINDING PROTEIN

(Staphylococcus
epidermidis) 		no annotation 4 GLY A 460
VAL A 462
PHE A 385
ILE A 492
 None
 1.12A 4xv2B-5bndA:
undetectable		 4xv2B-5bndA:
18.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5dl7 PORIN

(Acinetobacter
baumannii) 		PF03573
(OprD) 		4 GLY A 268
VAL A 304
PHE A 233
ILE A 252
 None
 1.14A 4xv2B-5dl7A:
undetectable		 4xv2B-5dl7A:
20.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5dqn CYTOCHROME P450
CYP125

(Mycolicibacterium
smegmatis) 		PF00067
(p450) 		4 GLY A  46
VAL A  92
PHE A 299
ILE A  80
 None
None
HEM  A 501 (-4.2A)
None
 1.08A 4xv2B-5dqnA:
undetectable		 4xv2B-5dqnA:
19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5dxx ARTEMISINIC ALDEHYDE
DELTA(11(13))
REDUCTASE

(Artemisia annua) 		PF00724
(Oxidored_FMN) 		4 GLY A 324
VAL A 328
PHE A  54
ILE A 314
 None
 1.14A 4xv2B-5dxxA:
undetectable		 4xv2B-5dxxA:
21.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5eqi SOLUTE CARRIER
FAMILY 2,
FACILITATED GLUCOSE
TRANSPORTER MEMBER 1

(Homo sapiens) 		PF00083
(Sugar_tr) 		4 GLY A  27
VAL A  32
PHE A 194
ILE A 192
 None
 1.11A 4xv2B-5eqiA:
undetectable		 4xv2B-5eqiA:
20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5g3z ADENYLATE KINSE

(synthetic
construct) 		PF00406
(ADK)
PF05191
(ADK_lid) 		4 GLY A  85
VAL A   4
PHE A 205
ILE A  20
 AP5  A1217 (-4.3A)
None
None
None
 1.17A 4xv2B-5g3zA:
undetectable		 4xv2B-5g3zA:
20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5im5 DESIGNED
KETO-HYDROXYGLUTARAT
E-ALDOLASE/KETO-DEOX
Y-PHOSPHOGLUCONATE
ALDOLASE

(Vibrionales
bacterium
SWAT-3) 		no annotation 4 GLY P 110
VAL P 108
PHE P  44
ILE P  70
 None
 1.15A 4xv2B-5im5P:
undetectable		 4xv2B-5im5P:
22.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ir6 BD-TYPE QUINOL
OXIDASE SUBUNIT I
BD-TYPE QUINOL
OXIDASE SUBUNIT II

(Geobacillus
stearothermophilus) 		PF01654
(Cyt_bd_oxida_I)
PF02322
(Cyt_bd_oxida_II) 		4 GLY A  76
VAL B  68
PHE A 152
ILE A  94
 HEB  A 502 (-3.4A)
None
None
None
 1.03A 4xv2B-5ir6A:
3.0		 4xv2B-5ir6A:
22.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kgn 2,3-BISPHOSPHOGLYCER
ATE-INDEPENDENT
PHOSPHOGLYCERATE
MUTASE

(Caenorhabditis
elegans) 		PF01676
(Metalloenzyme)
PF06415
(iPGM_N) 		4 GLY A  84
VAL A  76
PHE A 367
ILE A  93
 None
 0.87A 4xv2B-5kgnA:
undetectable		 4xv2B-5kgnA:
19.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mj7 UNCHARACTERIZED
PROTEIN

(Caenorhabditis
elegans) 		PF01156
(IU_nuc_hydro) 		4 GLY A  41
VAL A  45
PHE A  36
ILE A  52
 None
 1.12A 4xv2B-5mj7A:
undetectable		 4xv2B-5mj7A:
23.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5n94 CG9323, ISOFORM A

(Drosophila
melanogaster) 		no annotation 4 GLY A 423
VAL A 544
PHE A 475
ILE A 498
 None
 1.10A 4xv2B-5n94A:
undetectable		 4xv2B-5n94A:
15.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ols RHAMNOGALACTURONAN
LYASE

(Bacteroides
thetaiotaomicron) 		no annotation 4 GLY A 231
VAL A 258
PHE A 183
ILE A 193
 None
 1.09A 4xv2B-5olsA:
undetectable		 4xv2B-5olsA:
20.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tch TRYPTOPHAN SYNTHASE
BETA CHAIN

(Mycobacterium
tuberculosis) 		PF00291
(PALP) 		4 GLY B 176
VAL B 173
PHE B 188
ILE B 184
 None
 1.03A 4xv2B-5tchB:
undetectable		 4xv2B-5tchB:
22.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u09 CANNABINOID RECEPTOR
1,GLGA GLYCOGEN
SYNTHASE

(Homo sapiens;
Pyrococcus
abyssi) 		PF00001
(7tm_1)
PF00534
(Glycos_transf_1) 		4 GLY A1039
VAL A1048
PHE A1035
ILE A1116
 None
 1.15A 4xv2B-5u09A:
undetectable		 4xv2B-5u09A:
20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xap PROTEIN TRANSLOCASE
SUBUNIT SECD

(Deinococcus
radiodurans) 		PF02355
(SecD_SecF)
PF07549
(Sec_GG) 		4 GLY A 299
VAL A 357
PHE A 311
ILE A 307
 OLC  A 807 ( 4.5A)
None
None
None
 1.10A 4xv2B-5xapA:
undetectable		 4xv2B-5xapA:
16.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xmb PANTOTHENATE KINASE

(Mycobacterium
tuberculosis) 		no annotation 4 GLY A 168
VAL A  89
PHE A 218
ILE A  92
 None
 1.14A 4xv2B-5xmbA:
undetectable		 4xv2B-5xmbA:
14.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xog DNA-DIRECTED RNA
POLYMERASE SUBUNIT
BETA

(Komagataella
phaffii) 		PF00562
(RNA_pol_Rpb2_6)
PF04560
(RNA_pol_Rpb2_7)
PF04561
(RNA_pol_Rpb2_2)
PF04563
(RNA_pol_Rpb2_1)
PF04565
(RNA_pol_Rpb2_3)
PF04566
(RNA_pol_Rpb2_4)
PF04567
(RNA_pol_Rpb2_5) 		4 GLY B 282
VAL B 284
PHE B 325
ILE B 276
 None
 1.05A 4xv2B-5xogB:
undetectable		 4xv2B-5xogB:
13.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xyi RIBOSOMAL PROTEIN
S3AE, PUTATIVE

(Trichomonas
vaginalis) 		PF01015
(Ribosomal_S3Ae) 		4 GLY B 205
VAL B 136
PHE B 184
ILE B 208
 None
 1.14A 4xv2B-5xyiB:
undetectable		 4xv2B-5xyiB:
23.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6d6q EXOSOME RNA HELICASE
MTR4

(Homo sapiens) 		no annotation 4 GLY M 533
VAL M 535
PHE M 485
ILE M 390
 None
 1.07A 4xv2B-6d6qM:
undetectable		 4xv2B-6d6qM:
16.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6e9p -

(-) 		no annotation 4 GLY A 100
VAL A  49
PHE A  16
ILE A  55
 None
 1.13A 4xv2B-6e9pA:
undetectable		 4xv2B-6e9pA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6eio ANTIFREEZE PROTEIN

(uncultured
bacterium) 		no annotation 4 GLY A  79
VAL A  66
PHE A 206
ILE A 222
 None
 0.90A 4xv2B-6eioA:
undetectable		 4xv2B-6eioA:
18.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6f34 AMINO ACID
TRANSPORTER

(Geobacillus
kaustophilus) 		no annotation 4 GLY A  38
VAL A 317
PHE A 230
ILE A 234
 None
ARG  A 501 (-4.7A)
None
ARG  A 501 (-3.7A)
 1.13A 4xv2B-6f34A:
undetectable		 4xv2B-6f34A:
14.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6f9n PRE-MRNA 3' END
PROCESSING PROTEIN
WDR33

(Homo sapiens) 		no annotation 4 GLY B 244
VAL B 247
PHE B 272
ILE B 270
 None
 1.15A 4xv2B-6f9nB:
undetectable		 4xv2B-6f9nB:
13.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fa5 PUTATIVE MRNA
SPLICING FACTOR

(Chaetomium
thermophilum) 		no annotation 4 GLY A 507
VAL A 629
PHE A 558
ILE A 581
 None
None
ADP  A1001 (-3.3A)
None
 1.02A 4xv2B-6fa5A:
undetectable		 4xv2B-6fa5A:
12.94